Laboratory Asifa Akhtar

Zoom

DNA tightly packed together with histones into nucleosomes is not easily accessible to the enzymes that use it as a template for transcription or replication. Consequently, remodelling of chromatin structure may play an essential role in the regulation of gene expression. Structural changes in chromatin may also form the basis for dosage compensation mechanisms that have evolved to equalise levels of X-linked gene products between males and females. In humans, one of the two X chromosomes in females is randomly inactivated by condensation of the chromosome into a Barr body, a process known as X-inactivation. In contrast, in Drosophila this is achieved by a two fold hyper-transcription of the genes on the male X chromosome. Genetic studies have identified a number of factors that are important for dosage compensation in Drosophila, including five proteins [MSL1, MSL2, MSL3, MLE, MOF] and two non-coding RNAs [roX1 and roX2]. The hyperactive X is also specifically hyper-acetylated at histone H4, acetylation which is achieved by the MOF histone acetyl transferase.

Our major goal is to study the epigenetic mechanisms underlying X-chromosome specific gene regulation using Drosophila dosage compensation as a model system. More specifically, we are interested in addressing how the dosage compensation complex, composed of RNA and proteins [the MSL complex], gets targeted to the X chromosome. In addition, we are studying the mechanism by which the MSL complex modulates X chromosomal transcriptional output.


Senior Group Leader

Asifa Akhtar
phone: -565

akhtar@ie-freiburg.mpg.de

1971
Born in Karachi, Pakistan, Undergraduate studies in Biology at University College London, UK

1994-1997
PhD studies at Imperial Cancer Research Fund, London, UK

1998-2001
Postdoctoral fellow at EMBL, Heidelberg and the Adolf-Butenandt-Institut, Munich, Germany

2001 - 2009
Group Leader at EMBL, Heidelberg, Germany

Since 2009
Head of the Laboratory of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany

Project Areas

  • The role of non-coding RNA in dosage-compensation

    The role of non-coding RNA in dosage-compensation

    The involvement of non-coding RNAs as potential targeting molecules adds another level of complexity to chromatin regulation. Interestingly, the dosage...

    more details >

  • The role of the nuclear periphery in X chromosomal regulation

    The role of the nuclear periphery in X chromosomal regulation

    We have recently discovered the involvement of nuclear pore components in the regulation of dosage compensation in Drosophila. This work has raised several...

    more details >

  • The role of the NSL complex in gene regulation

    The role of the NSL complex in gene regulation

    We have recently biochemically purified a novel NSL complex that is associated with MOF histone acetyltransferase in Drosophila and mammals. Members of this...

    more details >

  • The function of the mammalian MSL complex

    The function of the mammalian MSL complex

    There is a remarkable evolutionary conservation of all the known Drosophila dosage compensation complex members in mammals. In fact, we have recently purified...

    more details >

Recent Publications

Group Members

Funding

  • Max Planck Society

    Max Planck Society

    The Max Planck Society is our main source of funding.

    more details >

  • EU FP7 EpiGeneSys

    EU FP7 EpiGeneSys

    Epigenetics advancing towards systems biology

    more details >

  • EU FP7 Nucleosome 4D

    EU FP7 Nucleosome 4D

    Marie Curie Initial Training Network

    more details >

  • DFG SFB 992

    DFG SFB 992

    Medical Epigenetics

    more details >

  • DFG SFB 746

    DFG SFB 746

    Functional specificity by coupling and modification of proteins

    more details >

  • BIOSS

    BIOSS

    Centre for Biological Signalling Studies

    more details >